glp-1 therapy for diabetes Beyond Blood Glucose: How GLP-1s are Changing Management Eating Behaviors May Predict GLP-1

For example, someone weighing 200 pounds could lose 20 to 30 pounds and maybe more

Glucagon-like Peptide-1 Receptor Agonists and Risk of Substance Use Disorders among US Veterans with Type 2 Diabetes: Cohort Study. BMJ , vol

If tangy is not your thing, you have options

A study published in Annals of Internal Medicine examined how glucagon-like peptide-1 receptor agonists (GLP-1RAs, also known as GLP-1 drugs), sold under brand names such as Ozempic, affected depression risk compared to two other medications used in diabetes treatment

Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for Parkinsons disease